Management of liver cirrhosis patients with heyponatremiarefractory ascites-acute kidney inyury
WANG Yu-ming

..............page:481-486

Prospective controlled trial of safety of human umbilical cord derived-mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis
LIN Hu;ZHANG Zheng;SHI Ming;XU Ruo-nan;FU Jun-liang;GENG Hua;LI Yuan-yuan;YU Shuang-jie;CHEN Li-ming;Lü Sa;WANG Fu-sheng

..............page:487-491

Significance of lipopolysaccharide binding protein in serum and ascites of patients with hepatic cirrhosis complicated with spontaneous bacterial peritonitis
TANG Neng-yuan;CHEN Wei-qing

..............page:492-496

Study of potential protective effects of blueberry on hepatic cytochrome P450 2E1 expression in rats with immune hepatic fibrosis
LU Shuang;CHENG Ming-liang;LI Hong;WU Jun

..............page:497-502

The mechanisms of inhibitory effect of adenovirus-mediated wild-type PTEN gene on the proliferation in activated hepatic stellate cells in vitro
HAO Li-sen;ZHANG Xiao-lan;WANG Jing;LI Li-wen;MO Yan-bo;ZHANG Chao;YAO Dong-mei;JIANG Hui-qing

..............page:503-506

Effect of reduced glutathione on proliferation of rat hepatic stellate cells and the Nrf2/HO-1 signaling pathway
ZHANG Li;ZHAO Long-feng;YANG Hui;ZHAO Jing-jing

..............page:507-511

A randomized, double-blind, double-dummy, controlled, multicenter study of entecavir maleate versus entecavir for treatment of HBeAg-negative chronic hepatitis B: results at week 48
XU Jing-hang;YU Yan-yan;SI Chong-wen;ZENG Zheng;LI Jun;MAO Qing;ZHANG Da-zhi;TANG Hong;SHENG Ji-fang;CHEN Xin-yue;NING Qin;SHI Guang-feng;XIE Qing;ZHANG Xi-quan;DAI Jun;XU Zhong-nan

..............page:512-516

Dynamics of serum HBV DNA levels during the terminal phases of acute-on-chronic hepatitis B liver failure with different HBeAg status
LAI Jing;GAN Wei-qiang;XIE Dong-ying;ZHANG Ka;KE Wei-min;GAO Zhi-liang

..............page:522-525

zhong hua gan zang bing za zhi gao yue

..............page:516,525,536,541,554,557,560,后插1-后插3

Assessment of the factors associated with insulin resistance in patients with chronic hepatitis B infection
DAI Fu-hong;ZENG Wei-qiong;JIANG Cui-ying

..............page:517-521

Effect of RNAi-mediated silencing of SREBP2 gene on inflammatory cytokine-induced cholesterol accumulation in HepG2 cells
LIAO Jun-lei;ZHAO Lei;CHEN Yao;LI Qing;CHEN Yu-yang;RUAN Xiong-zhong;CHEN Ya-xi

..............page:526-531

A nude mouse model of hepatocellular carcinoma single cell-derived organ site-specific metastasis
WAN Jin-liang;TAO Zhong-hua;WU Wei-zhong;TANG Jun;SUN Hui-chuan;WANG Lu;REN Zheng-gang;FAN Jia

..............page:532-536

Effect of magnesium isoglycrrhizinate on PLA2 during liver tissue injury following limb ischemia/reperfusion in rats
ZHANG Jin-chi;ZHENG Guo-fu;WU Ming-xiang;WU Jia-wen;OUYANG Liang-yuan;LIU Xue-qiang

..............page:537-541

Budd-Chiari syndrome associated with hypereosinophilic syndrome: a case report
LI Chan;PAN Xiu-cheng;CHEN Ming

..............page:553-554

Does the epithelial-to-mesenchymal transition exist in liver fibrosis?
TONG Xiao-fei;YANG Ai-ting;WANG Ping;YOU Hong

..............page:555-557

Progress in infectious etiology of infantile hepatitis syndrome
ZHENG Jia-jia;XU Hong-mei

..............page:558-560

Atomic force microscopic observation and three-dimensional reconstruction of hepatitis immunoglobulins blocking hepatitis B virus infection of choriocarcinom JAR cells
GAN Lu;XIAO Xiao-min;WEI Ming

..............page:542-544

Analysis of suspected hepatitis B virus genotype Ⅰ from one patient in Guizhou province
YANG Xing-lin;HUANG Hai;WANG Yi-guang;LI Yong-fu;TIAN Jie

..............page:545-546

HCV genotype distribution among 650 patients in Shenyang with chronic hepatitis C
XU Chun;ZHANG Ming-xiang;WEI Ni;LI Bai-jun

..............page:547-548

Role of N-acetylcysteine and magnesium on liver fibrosis
ZHUANG Rang-xiao;WANG Fu-gen;ZHOU Hong-ping;FANG Hong-ying;MIAO Liang-bin;SHAO Yi-dan

..............page:549-550

Application of 64-slice CT perfusion imaging in the diagnosis of alcoholic fatty liver disease
WANG Fang-jun;XIANG Bin;LIU Peng-fei;MENG Xian-ping;ZHU Jian-xin

..............page:551-552